Drug Safety Information for CYMBALTA (Duloxetine hydrochloride)

Safety-related Labeling Changes for CYMBALTA (DULOXETINE) Rx Drug: FDA Link

Safety-related Labeling Changes for DRIZALMA SPRINKLE (DULOXETINE HYDROCHLORIDE) Rx Drug: FDA Link

Adverse Drug Reactions for CYMBALTA* (Duloxetine hydrochloride)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with CYMBALTA
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Nausea*4913
2Dizziness*3539
3Drug ineffective3427
4Headache*3422
5Fatigue*3395
6Pain3317
7Depression2952
8Insomnia*2695
9Anxiety2413
10Feeling abnormal2299
11Fall2244
12Vomiting2242
13Diarrhoea2209
14Drug withdrawal syndrome2024
15Paraesthesia1942
16Dyspnoea1896
17Malaise1776
18Suicidal ideation1757
19Asthenia1732
20Somnolence*1715

* This side effect also appears in "Top 10 Side Effects of CYMBALTA " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking CYMBALTA
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Depression*64042
2Product used for unknown indication24838
3Fibromyalgia*12306
4Pain*6756
5Anxiety*4917
6Neuralgia*4570
7Major depression*4107
8Neuropathy peripheral*3335
9Diabetic neuropathy1885
10Back pain*1828

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for CYMBALTA

Total Reports Filed with FDA: 261155


Number of FDA Adverse Event Reports by Patient Age for CYMBALTA

Total Reports Filed with FDA: 261155*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Duloxetine hydrochloride (Duloxetine, Cymbalta)

Charts are based on 261155 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and CYMBALTA Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.